Mild anxiogenic effects of nicotine withdrawal in mice

被引:30
|
作者
Jonkman, S [1 ]
Henry, B [1 ]
Semenova, S [1 ]
Markou, A [1 ]
机构
[1] Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA
关键词
light-dark box; anxiety; nicotine; startle; withdrawal; prepulse inhibition; (mouse);
D O I
10.1016/j.ejphar.2005.04.032
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Increased anxiety is one of the symptoms of nicotine withdrawal that may lead to relapse. Previous studies have shown that nicotine withdrawal affects anxiety-like behavior in different tests of anxiety in humans and rats. However, relatively few studies have focused on the anxiogenic effect of nicotine withdrawal in mice. The present study investigated the effect of nicotine withdrawal on anxiety-like behavior in DBA/2J and C57BL/6J mouse strains in the light-dark box, acoustic startle response, and prepulse inhibition tests. An initial experiment showed that nicotine administration of 12 or 24 mg/kg/day (free base) for 14 days did not result in significant effects during withdrawal in startle, prepulse inhibition, or light-dark box, but there was a trend towards an anxiogenic effect in the light-dark box 24 h, but not 1 or 4 h, after cessation of nicotine administration. A subsequent study was therefore performed, with minipumps delivering saline, 24 mg/kg/day nicotine, or 48 mg/kg/day nicotine (free base), for 14 days. The pumps were removed, and the mice were tested 24 h after cessation of nicotine administration. Cessation of administration of 48 mg/kg/day nicotine free base in C57BL/6J mice resulted in increased anxiety-like behavior in the light-dark box, while the behavior of DBA/2J mice was unaffected. The acoustic startle response and prepulse inhibition were also unaffected in both strains. In conclusion, the present data show that nicotine withdrawal is mildly anxiogenic in C57BL/6J mice under the conditions used in the present experiments. (c) 2005 Elsevier B.V All rights reserved.
引用
收藏
页码:40 / 45
页数:6
相关论文
共 50 条
  • [1] Effects of Nicotine Metabolites on Nicotine Withdrawal Behaviors in Mice
    Elhassan, Sagi
    Bagdas, Deniz
    Damaj, M. Imad
    [J]. NICOTINE & TOBACCO RESEARCH, 2017, 19 (06) : 763 - 766
  • [2] Affective, somatic and anxiogenic-like aspects of spontaneous and precipitated nicotine withdrawal in mice
    Semenova, S.
    Stoker, A. K.
    Markou, A.
    [J]. BEHAVIOURAL PHARMACOLOGY, 2007, 18 : S32 - S32
  • [3] Nicotine anxiogenic and rewarding effects are decreased in mice lacking β-endorphin
    Trigo, Jose M.
    Zimmer, Andreas
    Maldonado, Rafael
    [J]. NEUROPHARMACOLOGY, 2009, 56 (08) : 1147 - 1153
  • [4] Affective, somatic and anxiogenic-like aspects of spontaneous and precipitated nicotine withdrawal in mice
    Semenova, S.
    Stoker, A. K.
    Markou, A.
    [J]. BIOCHEMICAL PHARMACOLOGY, 2007, 74 (08) : SMA47 - SMA47
  • [5] The Anxiogenic Effects of Caffeine Do Not Potentiate Nicotine Withdrawal in an Elevated Plus Maze Model of Anxiety
    Swalve, Natashia
    Bierlein, Elizabeth
    [J]. JOURNAL OF CAFFEINE AND ADENOSINE RESEARCH, 2020, 10 (03) : 110 - 116
  • [6] Anxiogenic effects of cocaine withdrawal in zebrafish
    Lopez-Patino, Marcos A.
    Yu, Lili
    Cabral, Howard
    Zhdanova, Irina V.
    [J]. PHYSIOLOGY & BEHAVIOR, 2008, 93 (1-2) : 160 - 171
  • [7] Reward Sensitization: Effects of Repeated Nicotine Exposure and Withdrawal in Mice
    Monica R F Hilario
    Jill R Turner
    Julie A Blendy
    [J]. Neuropsychopharmacology, 2012, 37 : 2661 - 2670
  • [8] Reward Sensitization: Effects of Repeated Nicotine Exposure and Withdrawal in Mice
    Hilario, Monica R. F.
    Turner, Jill R.
    Blendy, Julie A.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2012, 37 (12) : 2661 - 2670
  • [9] Animal models of the anxiogenic effects of ethanol withdrawal
    Gatch, MB
    Lal, H
    [J]. DRUG DEVELOPMENT RESEARCH, 2001, 54 (02) : 95 - 115
  • [10] Spontaneous nicotine withdrawal produces anxiogenic-like effects reflected in increased light potentiated startle in rats
    Risbrough, Victoria
    Jonkman, Sietse
    Geyer, Mark
    Markou, Athina
    [J]. NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S207 - S207